Menopausal Hormone Therapy Linked to Faster Regional Tau Accumulation in Older Women
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 12, 2025 -- For older women, menopausal hormone therapy (HT) use is associated with faster regional tau accumulation, according to a study published in the March 5 issue of Science Advances.
Gillian T. Coughlan, Ph.D., from Massachusetts General Hospital in Boston, and colleagues examined the extent to which menopausal HT use is associated with later-life amyloid-β (Aβ) and tau accumulation using positron emission tomography in a study involving 146 clinically normal women at baseline, aged 51 to 89 years. About 14 years after initiation of HT, the women were scanned during a 4.5- and 3.5-year period for Aβ and tau, respectively.
The researchers found that HT users exhibited faster regional tau accumulation relative to nonusers among older women (older than 70 years), with accumulation localized to the entorhinal cortex and the inferior temporal and fusiform gyri; HT had an indirect effect on cognitive decline through regional tau accumulation. HT associations with tau were negligible among younger women (younger than 70 years).
"Our data show that HT use predicts tau accumulation as a function of age, with implications for cognitive decline. Secular trends in the prescribing patterns of HT may explain the age-dependent effect of HT on tau progression," the authors write. "The findings may inform Alzheimer disease risk discussions relating to women's reproductive health and treatment."
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
2015 to 2021 Saw Decrease in Incidence of Dementia
FRIDAY, May 23, 2025 -- From 2015 to 2021, there was a decrease in the incidence of dementia, but an increase in prevalence, according to a study published online May 20 in The...
Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease
THURSDAY, May 22, 2025 -- Herpes simplex virus type 1 (HSV-1) is associated with an increased risk for Alzheimer disease (AD) based on real-world data from the United States...
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.